Mapping the role of pH-adjusted potassium in diabetic ketoacidosis: Hypokalemia and the patient outcomes.
Atif UsmanNorlaila MustafaSaleem Perwaiz IqbalMd Zobaer HasanMohd Farooq ShaikhJuman Abdulelah DujailiSiew Hua GanPublished in: International journal of clinical practice (2021)
pH-adjusted potassium shall be used as a marker for hypokalemia and to initiate potassium replacement instead of measured serum potassium in DKA. Utilising pHK will help to avoid hypokalemia, reduce its severity and shorten ED care which will subsequently reduce hospitalisation length. We expect pHK to improve pharmacoeconomics in the future.